BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1394122)

  • 1. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis.
    Sánchez A; Fabregat I
    Clin Transl Oncol; 2009 Apr; 11(4):208-14. PubMed ID: 19380297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.
    Nicholes K; Guillet S; Tomlinson E; Hillan K; Wright B; Frantz GD; Pham TA; Dillard-Telm L; Tsai SP; Stephan JP; Stinson J; Stewart T; French DM
    Am J Pathol; 2002 Jun; 160(6):2295-307. PubMed ID: 12057932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone-dependent overexpression of cytochromes P450 2A in liver tumors of TGF alpha transgenic male mice.
    Takagi H; Aida K; Sohara N; Mori M; Merlino G; Negishi M
    J Gastroenterol; 1997 Oct; 32(5):708-11. PubMed ID: 9350003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats.
    Dombrowski F; Bannasch P; Pfeifer U
    Am J Pathol; 1997 Mar; 150(3):1071-87. PubMed ID: 9060843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.
    Takayama H; LaRochelle WJ; Sharp R; Otsuka T; Kriebel P; Anver M; Aaronson SA; Merlino G
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):701-6. PubMed ID: 9012848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II.
    Ueda K; Ganem D
    J Virol; 1996 Mar; 70(3):1375-83. PubMed ID: 8627653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers.
    Tanaka S; Takenaka K; Matsumata T; Mori R; Sugimachi K
    Dig Dis Sci; 1996 Jan; 41(1):208-15. PubMed ID: 8565758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
    Sandgren EP; Luetteke NC; Qiu TH; Palmiter RD; Brinster RL; Lee DC
    Mol Cell Biol; 1993 Jan; 13(1):320-30. PubMed ID: 8417334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet growth factors: curing diabetes and preventing chronic pancreatitis?
    Korc M
    J Clin Invest; 1993 Sep; 92(3):1113-4. PubMed ID: 8376573
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice.
    Webber EM; Wu JC; Wang L; Merlino G; Fausto N
    Am J Pathol; 1994 Aug; 145(2):398-408. PubMed ID: 8053497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial factors in the development and progression of breast cancer.
    Hilakivi-Clarke L; Rowland J; Clarke R; Lippman ME
    Breast Cancer Res Treat; 1994 Feb; 29(2):141-60. PubMed ID: 8012033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha.
    Wu JC; Merlino G; Fausto N
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):674-8. PubMed ID: 7904757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal factors increase breast cancer risk.
    Hilakivi-Clarke L; Clarke R; Lippman ME
    Breast Cancer Res Treat; 1994; 31(2-3):273-84. PubMed ID: 7881105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased susceptibility to N-nitrosomethylurea gastric carcinogenesis in transforming growth factor alpha transgenic mice with gastric hyperplasia.
    Tamano S; Jakubczak J; Takagi H; Merlino G; Ward JM
    Jpn J Cancer Res; 1995 May; 86(5):435-43. PubMed ID: 7790317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
    Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C; Takayama H; Dickson RB; Merlino G
    Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.